Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Prevention of Cross Contamination during Drying – V 2.0

Posted on By

API Manufacturing: SOP for Prevention of Cross Contamination during Drying – V 2.0

Standard Operating Procedure for Prevention of Cross Contamination during Drying in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/073/2025
Supersedes SOP/API/073/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for preventing cross contamination during drying processes of Active Pharmaceutical Ingredients (APIs) in the manufacturing facility, ensuring compliance with cGMP and product quality.

2. Scope

This SOP is applicable to all drying operations including tray drying, vacuum drying, fluid bed drying, and rotary drying performed in the API manufacturing areas.

3. Responsibilities

  • Production Operator: Follow prescribed practices to prevent cross contamination.
  • Production Supervisor: Verify adherence to preventive measures and perform risk assessments.
  • QA Department: Ensure area cleanliness, review cleaning records, and validate preventive practices.
  • Engineering Department: Maintain integrity of drying equipment and air handling units (AHUs).
See also  API Manufacturing: SOP for In-Process Sampling Technique - V 2.0

4. Accountability

The Production Head is accountable for implementation of cross contamination prevention measures. QA Head is responsible for compliance monitoring and audit readiness.

5. Procedure

5.1 Equipment and Area Cleaning

  1. Ensure all drying equipment (FBD, tray dryer, vacuum dryer) is cleaned as per validated cleaning SOP before and after use.
  2. Verify cleaning status label is displayed as “Cleaned” with date and sign.
  3. Use dedicated cleaning tools for each drying area to prevent cross-use.

5.2 Batch and Product Segregation

  1. Do not dry different products or batches simultaneously in the same chamber or area.
  2. If multiple dryers are used in parallel, maintain physical separation and labeled identification of each dryer and batch.
  3. Implement scheduling to allow drying of only one product per session.

5.3 Environmental and Personnel Controls

  1. Ensure personnel wear product-specific PPE and change it when moving between product zones.
  2. Minimize human movement and material exposure during transfer to and from drying units.
  3. Monitor temperature, humidity, and particulate matter as per environmental control plan.
See also  API Manufacturing: SOP for Vendor Qualification and Approval Process - V 2.0

5.4 Equipment Integrity and Design

  1. Ensure all dryers are leak-free and have proper sealing mechanisms (e.g., door gaskets, clamps).
  2. Use HEPA filters where applicable, and monitor differential pressure in ducting to detect leaks.
  3. Perform regular maintenance and integrity testing of equipment and associated air handling units.

5.5 Line Clearance and Documentation

  1. QA must perform and document line clearance before and after each drying operation.
  2. Ensure that no remnants of previous batch/product remain in trays, ducts, or containers.
  3. Record preventive actions and inspections in “Cross Contamination Prevention Log” (Annexure-1).

5.6 Risk Mitigation and Validation

  1. Perform risk assessment for products with high cross-contamination potential (e.g., cytotoxics, beta-lactams).
  2. Validate cleaning processes and recovery limits for each product changeover.
  3. Review trends from environmental monitoring and product cross-checks in retained samples.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • SOP: Standard Operating Procedure
  • FBD: Fluid Bed Dryer
  • QA: Quality Assurance
  • AHU: Air Handling Unit
  • PPE: Personal Protective Equipment
See also  API Manufacturing: SOP for Reconciliation of Issued and Returned Materials - V 2.0

7. Documents

  1. Cross Contamination Prevention Log (Annexure-1)
  2. Cleaning Checklist
  3. Environmental Monitoring Record
  4. Batch Manufacturing Record

8. References

  • WHO TRS 986 Annex 2 – GMP for APIs
  • EU Guidelines on Cross Contamination (Chapter 3 and 5)
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Cross Contamination Prevention Log

Date Dryer ID Batch No. Cleaning Verified Line Clearance Done Remarks Checked By
13/04/2025 VCD-02 API-20250413 Yes Yes Clean & Clear

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release New Compliance Requirement QA Head
13/04/2025 2.0 Added Risk Assessment and Validation Elements Regulatory Inspection Readiness QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Creams: SOP for Conducting Rheological Analysis of Creams – V 2.0
Next Post: Analytical Method Development: Reference Standard Qualification for AMD – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version